Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada

Kimberly A Nichol1, George G Zhanel, Daryl J Hoban

  • 1Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Health Sciences Centre, Winnipeg, Manitoba, Canada. knichol@hsc.mb.ca

Insights

Penicillin resistance in Streptococcus pneumoniae shows clonal spread, but ciprofloxacin resistance does not. Ciprofloxacin-resistant strains in Canada are not primarily spreading through clonal dissemination.

Area of Science:

  • Microbiology
  • Genetics
  • Epidemiology

Background:

  • Streptococcus pneumoniae is a leading cause of bacterial infections worldwide.
  • Antibiotic resistance, particularly to penicillin and ciprofloxacin, poses a significant public health threat.
  • Understanding the genetic basis and dissemination patterns of antibiotic resistance is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the genetic diversity and dissemination mechanisms of penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae isolates in Canada.
  • To compare the genotypic variability associated with penicillin resistance versus ciprofloxacin resistance in S. pneumoniae.

Main Methods:

  • Serotyping was performed on 89 resistant Streptococcus pneumoniae isolates.
  • Pulsed-field gel electrophoresis (PFGE) was used to assess genotypic variability.
  • Isolates resistant to penicillin and ciprofloxacin were analyzed.

Main Results:

  • Penicillin-resistant Streptococcus pneumoniae isolates exhibited significant genetic homogeneity, suggesting clonal spread.
  • Conversely, ciprofloxacin resistance did not correlate with reduced genotypic variability among the isolates.
  • The genetic diversity of ciprofloxacin-resistant strains was substantial.

Conclusions:

  • The spread of penicillin resistance in Streptococcus pneumoniae appears to be driven by clonal dissemination.
  • The dissemination of ciprofloxacin resistance in S. pneumoniae in Canada is not currently attributable to clonal spread.
  • Further research is needed to elucidate the mechanisms driving the spread of ciprofloxacin resistance in S. pneumoniae.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...